Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
03 6월 2024 - 8:30PM
Evome Medical Technologies Inc. (the “
Company” or
“
Evome”) (TSXV: EVMT) today provided details on
preliminary estimated revenues and margins from April and May 2024,
the first two months of the second quarter. Mike Seckler, Chief
Executive Officer of the Company, will also hold a call to update
shareholders on the first quarter financials, second quarter
progress and future plans of the Company.
Revenue Growth Update for Q2 2024
- For April and May 2024, combined
preliminary estimated revenue of Biodex Medical Systems, Inc.
(“Biodex”) and DaMar Plastics Manufacturing, Inc.
(“DaMar”) stood at $3,970,496 with a gross margin
of 36%.
- As a comparison, preliminary
estimated Q2 2024 revenues are projected to be 39% higher with
increasing gross margins as compared to Q1 2024 revenues for Biodex
and DaMar.
- In addition to intending on
divesting DaMar, announced by the Company on May 30,
2024, in 2025, the Company plans to divest operating
subsidiaries, South Dakota Partners Inc. and Mio-Guard LLC, in the
coming quarters to reduce debt. On a going forward basis, Evome
will offer financial comparisons for its core business, Biodex, and
its other remaining asset, Damar.
Details for Call-in
5 p.m. EST on June 4, 2024
Dial-in number: (516) 253-3240Access code:
918273 if prompted
Mike Seckler Chief Executive Officer Tel: 1 (800)
760-6826 Email: Info@Salonaglobal.com
Cautionary Statements
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Unless otherwise specified, all financial
information is presented in Canadian dollars ("$", "dollars" and
"C$").
There can be no assurance that any disposition
(including the proposed dispositions disclosed herein) will be
completed or the sale price or timing of any disposition.
Completion of any transaction will be subject to, amongst other
things, negotiation and execution of definitive agreements, and
applicable director, shareholder and regulatory approvals.
Certain statements contained in this press
release constitute "forward-looking information" within the meaning
of the Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities laws. These statements can be
identified by the use of forward-looking terminology such as
“expects” “believes”, “estimates”, "may", "would", "could",
"should", "potential", "will", "seek", "intend", "plan", and
"anticipate", and similar expressions as they relate to the
Company, including: the financial results of the second quarter;
and the Company successfully disposing of any subsidiaries. All
statements other than statements of historical fact may be
forward-looking information. Such statements reflect the Company's
current views and intentions with respect to future events, and
current information available to the Company, and are subject to
certain risks, uncertainties and assumptions, including: the
completion of normal quarter and year end accounting procedures and
adjustments not resulting in any material differences; and the
Company successfully identifying a buyer for a non-core business
and negotiating and closing a sale. The Company cautions that the
forward-looking statements contained herein are qualified by
important factors that could cause actual results to differ
materially from those reflected by such statements. Such factors
include but are not limited to the general business and economic
conditions in the regions in which the Company operates; the
ability of the Company to execute on key priorities, including the
successful completion of acquisitions, business retention, and
strategic plans and to attract, develop and retain key executives;
difficulty integrating newly acquired businesses; ongoing or new
disruptions in the supply chain, the extent and scope of such
supply chain disruptions, and the timing or extent of the
resolution or improvement of such disruptions; the ability to
implement business strategies and pursue business opportunities;
disruptions in or attacks (including cyber-attacks) on the
Company’s information technology, internet, network access or other
voice or data communications systems or services; the evolution of
various types of fraud or other criminal behavior to which the
Company is exposed; the failure of third parties to comply with
their obligations to the Company or its affiliates; the impact of
new and changes to, or application of, current laws and
regulations; granting of permits and licenses in a highly regulated
business; the overall difficult litigation environment, including
in the United States; increased competition; changes in foreign
currency rates; increased funding costs and market volatility due
to market illiquidity and competition for funding; the availability
of funds and resources to pursue operations; critical accounting
estimates and changes to accounting standards, policies, and
methods used by the Company; the occurrence of natural and
unnatural catastrophic events and claims resulting from such
events; as well as those risk factors discussed or referred to in
the Company’s disclosure documents filed the securities regulatory
authorities in certain provinces of Canada and available at
www.sedarplus.ca. Should any factor affect the Company in an
unexpected manner, or should assumptions underlying the
forward-looking information prove incorrect, the actual results or
events may differ materially from the results or events predicted.
Any such forward-looking information is expressly qualified in its
entirety by this cautionary statement. Moreover, the Company does
not assume responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information
included in this press release is made as of the date of this press
release and the Company undertakes no obligation to publicly update
or revise any forward-looking information, other than as required
by applicable law.
Preliminary Financial Metrics
This press release contains certain pre-released
financial metrics. The financial metrics contained in this press
release are preliminary and represent the most current information
available to the Company's management, as financial closing
procedures for the second quarter ended June 30, 2024, are not yet
complete. The Company's actual consolidated financial statements
for such period , and for the year ended December 31, 2024, may
result in material changes to the financial metrics summarized in
this press release (including by any one financial metric, or all
of the financial metrics, being below or above the figures
indicated) as a result of the completion of normal quarter and year
end accounting procedures and adjustments, and also what one might
expect to be in the final consolidated financial statements based
on the financial metrics summarized in this press release. Although
the Company believes the expectations reflected in this press
release are based upon reasonable assumptions, the Company can give
no assurance that actual results will not differ materially from
these expectations.
Evome Medical Technologies (TSXV:EVMT)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Evome Medical Technologies (TSXV:EVMT)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024